The novel coronavirus outbreak makes the standard 10-year process for vaccine development untenable. Yet there is little existing data or evidence about COVID-19. To overcome this dearth, health systems caring for patients are constantly tracking and recording new data about the virus. Access to this primary source for COVID-19 near real-time patient data is vital for research teams to stay current during their life-saving work on vaccines, therapeutics, and clinical trials of all kinds. Learn more about this critical database.
Because knowledge about COVID-19 is continually evolving, the need for population-based research and real-world evidence at a national scale is critical. The most effective research includes the latest, point-of-care data that development teams can leverage to steer R&D and commercialization.
- Sadiqa Mahmood, DDS, MPH General Manager & SVP, Life Sciences Business
Health Catalyst | 3165 Millrock Dr. #400 | Salt Lake City, UT 84121 Tel: 855-309-6800
Want to reach 137,000+ Fierce Biotech subscribers with your own message? Contact [email protected] or call 202-824-5074.
